File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: IL2-receptor antagonist (basiliximab) induction therapy is associated with lower morbidity and mortality in renal transplant recipients

TitleIL2-receptor antagonist (basiliximab) induction therapy is associated with lower morbidity and mortality in renal transplant recipients
Authors
Choy, BYChan, TMLi, FKLui, SLLo, WKYip, TTse, KCLai, KN
Issue Date2003
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/transproceed
Citation
Transplantation Proceedings, 2003, v. 35 n. 1, p. 195 How to Cite?
DOI: http://dx.doi.org/10.1016/S0041-1345(02)03980-5
Persistent Identifierhttp://hdl.handle.net/10722/76472
ISSN
0041-1345
2021 Impact Factor: 1.014
2020 SCImago Journal Rankings: 0.373
ISI Accession Number ID
WOS:000181017200080
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorChoy, BYen_HK
dc.contributor.authorChan, TMen_HK
dc.contributor.authorLi, FKen_HK
dc.contributor.authorLui, SLen_HK
dc.contributor.authorLo, WKen_HK
dc.contributor.authorYip, Ten_HK
dc.contributor.authorTse, KCen_HK
dc.contributor.authorLai, KNen_HK
dc.date.accessioned2010-09-06T07:21:36Z-
dc.date.available2010-09-06T07:21:36Z-
dc.date.issued2003en_HK
dc.identifier.citationTransplantation Proceedings, 2003, v. 35 n. 1, p. 195en_HK
dc.identifier.issn0041-1345en_HK
dc.identifier.urihttp://hdl.handle.net/10722/76472-
dc.languageengen_HK
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/transproceeden_HK
dc.relation.ispartofTransplantation Proceedingsen_HK
dc.rightsTransplantation Proceedings. Copyright © Elsevier Inc.en_HK
dc.subject.meshAdulten_HK
dc.subject.meshAntibodies, Monoclonal - therapeutic useen_HK
dc.subject.meshDrug Therapy, Combinationen_HK
dc.subject.meshFemaleen_HK
dc.subject.meshGraft Rejection - epidemiologyen_HK
dc.subject.meshHumansen_HK
dc.subject.meshImmunosuppressive Agents - therapeutic useen_HK
dc.subject.meshKidney Transplantation - adverse effects - immunologyen_HK
dc.subject.meshMaleen_HK
dc.subject.meshMorbidityen_HK
dc.subject.meshPostoperative Complications - classification - epidemiology - prevention & controlen_HK
dc.subject.meshRecombinant Fusion Proteinsen_HK
dc.subject.meshRetrospective Studiesen_HK
dc.titleIL2-receptor antagonist (basiliximab) induction therapy is associated with lower morbidity and mortality in renal transplant recipientsen_HK
dc.typeConference_Paperen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0041-1345&volume=35&spage=195&epage=&date=2003&atitle=IL2-Receptor+Antagonist+(Basiliximab)+Induction+Therapy+is+Associated+with+Lower+Morbidity+and+Mortality+in+Renal+Transplant+Recipientsen_HK
dc.identifier.emailChan, TM: dtmchan@hku.hken_HK
dc.identifier.emailLai, KN: knlai@hku.hken_HK
dc.identifier.authorityChan, TM=rp00394en_HK
dc.identifier.authorityLai, KN=rp00324en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/S0041-1345(02)03980-5en_HK
dc.identifier.pmid12591363-
dc.identifier.scopuseid_2-s2.0-0345382846en_HK
dc.identifier.hkuros81129en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0345382846&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume35en_HK
dc.identifier.issue1en_HK
dc.identifier.spage195en_HK
dc.identifier.epage195en_HK
dc.identifier.isiWOS:000181017200080-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridChoy, BY=7003465499en_HK
dc.identifier.scopusauthoridChan, TM=7402687700en_HK
dc.identifier.scopusauthoridLi, FK=55210612400en_HK
dc.identifier.scopusauthoridLui, SL=7102379130en_HK
dc.identifier.scopusauthoridLo, WK=7201502414en_HK
dc.identifier.scopusauthoridYip, T=7004283977en_HK
dc.identifier.scopusauthoridTse, KC=7102609864en_HK
dc.identifier.scopusauthoridLai, KN=7402135706en_HK
dc.identifier.issnl0041-1345-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats